新時達(002527.SZ):“時達轉債”的附加回售條款生效
格隆匯 2 月 9日丨新時達(002527.SZ)公佈,公司於2021年1月20日召開的第五屆董事會第七次會議和第五屆監事會第四次會議以及於2021年2月8日召開的2021年第一次債券持有人會議和2021年第一次臨時股東大會分別審議通過了《關於變更募集資金用途並永久補充流動資金的議案》。根據《募集説明書》的約定,“時達轉債”的附加回售條款生效。
回售價格為100.432元人民幣/張(含息税);回售申報期為2021年2月22日至2021年2月26日;發行人資金到賬日為2021年3月3日;回售款劃撥日為2021年3月4日;投資者回售款到賬日為2021年3月5日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.